Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
nontarget lesion | disease site followed without inclusion in the target measurement total | Nontarget lesion was described separately from the measured lesions. | Assessment | Cancer, treatment response and transplant assessment |
radiologic response | change in tumor findings on imaging after treatment | The radiologic response was assessed against the pretreatment scan. | Assessment | Cancer, treatment response and transplant assessment |
pathologic complete response | no residual cancer meeting the protocol's pathologic response definition in assessed tissue | The pathologic complete response was reported with the sites and criteria evaluated. | Assessment | Cancer, treatment response and transplant assessment |
residual viable tumor | living tumor remains in the examined tissue after treatment | Residual viable tumor was quantified in the resection specimen. | Assessment | Cancer, treatment response and transplant assessment |
measurable residual disease | low-level disease detected after treatment by a specified sensitive method | Measurable residual disease was reported with assay sensitivity and specimen source. | Assessment | Cancer, treatment response and transplant assessment |
biochemical recurrence | return of a disease-associated marker meeting the relevant recurrence criterion | Biochemical recurrence was assessed using the named marker and disease-specific definition. | Assessment | Cancer, treatment response and transplant assessment |
stable disease | neither enough shrinkage nor enough growth to meet the specified response or progression criteria | Stable disease was recorded under the response system used by oncology. | Assessment | Cancer, treatment response and transplant assessment |
progressive disease | worsening that meets the applicable disease-specific progression criteria | Progressive disease was documented with the comparison study and criterion. | Assessment | Cancer, treatment response and transplant assessment |
mixed response | some lesions improve while others worsen | The mixed response was noted because the measured liver lesion shrank while another lesion enlarged. | Assessment | Cancer, treatment response and transplant assessment |
pseudoprogression | apparent early worsening that may later prove to be treatment-related change | Pseudoprogression remains a consideration pending the planned follow-up study. | Assessment | Cancer, treatment response and transplant assessment |
tumor flare | temporary increase in symptoms or findings after treatment that requires context | Tumor flare was considered alongside true progression. | Assessment | Cancer, treatment response and transplant assessment |
dose-limiting toxicity | adverse effect meeting a protocol's rule limiting further dose escalation | Dose-limiting toxicity was classified using the treatment protocol. | Assessment | Cancer, treatment response and transplant assessment |
treatment-emergent event | event that began or worsened after treatment started | Treatment-emergent event was documented with onset and attribution assessed separately. | Assessment | Cancer, treatment response and transplant assessment |
performance status | standardized estimate of function and ability to carry out daily activity | Performance status was recorded with the scale and assessment date. | Assessment | Cancer, treatment response and transplant assessment |
line of therapy | ordered position of a systemic regimen in a patient's treatment history | Line of therapy was confirmed from the oncology records. | Assessment | Cancer, treatment response and transplant assessment |
adjuvant therapy | additional treatment after primary therapy intended to reduce recurrence risk | Adjuvant therapy was discussed following surgical pathology review. | Assessment | Cancer, treatment response and transplant assessment |
neoadjuvant therapy | treatment given before the planned primary local treatment | Neoadjuvant therapy was completed before the surgical reassessment. | Assessment | Cancer, treatment response and transplant assessment |
maintenance therapy | ongoing treatment intended to maintain disease control after an initial phase | Maintenance therapy was reviewed against the patient's goals and tolerance. | Assessment | Cancer, treatment response and transplant assessment |
salvage therapy | treatment considered after prior treatment has failed or disease has returned | Salvage therapy was discussed at the multidisciplinary visit. | Assessment | Cancer, treatment response and transplant assessment |
treatment intent | goal of a course of treatment, such as cure, control or symptom relief | Treatment intent was specified during shared decision-making. | Assessment | Cancer, treatment response and transplant assessment |
allograft dysfunction | reduced function of a transplanted organ from any of several possible causes | Allograft dysfunction was assessed against the patient's baseline and timing after transplant. | Assessment | Cancer, treatment response and transplant assessment |
delayed graft function | early failure of a kidney graft to function adequately under the transplant team's definition | Delayed graft function was documented with dialysis use and urine output after transplant. | Assessment | Cancer, treatment response and transplant assessment |
graft survival | continued function or retention of a transplanted organ under a stated definition | Graft survival was reported with the follow-up interval. | Assessment | Cancer, treatment response and transplant assessment |
acute cellular rejection | immune injury to an allograft involving a cellular response | Acute cellular rejection was documented using the transplant biopsy interpretation. | Assessment | Cancer, treatment response and transplant assessment |
antibody-mediated rejection | allograft injury meeting organ-specific criteria for an antibody-mediated process | Antibody-mediated rejection was classified using the transplant service's findings. | Assessment | Cancer, treatment response and transplant assessment |